查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606600

梭菌诊断市场：按诊断测试、最终用户划分 - 2025-2030 年全球预测

Clostridium Diagnostics Market by Diagnostic Test (Blood Test, Colonoscopy/Sigmoidoscopy, Enzyme Immunoassays), End User (Diagnostic Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年，梭菌诊断市场价值为 14.3 亿美元，预计到 2024 年将达到 15.1 亿美元，复合年增长率为 6.33%，到 2030 年将达到 22 亿美元。

梭菌诊断的范围包括梭状菌感染的检测、识别和管理，尤其是困难梭状芽孢桿菌，事实上，由于其与抗生素相关的腹泻和结肠炎的相关性，它在医疗保健环境中是一个重要的问题。这个诊断领域至关重要，因为梭状菌感染可能会造成严重后果，需要及时、准确的诊断，以限制感染的传播并优化治疗途径。应用在医院、学术研究中心和诊断实验室中非常突出，支持有效的感染控制和病患管理策略。最终用途范围从医疗保健到开发新诊断技术的生物技术公司。

主要市场统计
基准年[2023] 14.3亿美元
预测年份 [2024] 15.1亿美元
预测年份 [2030] 22亿美元
复合年增长率（%） 6.33%

市场成长受到梭状菌感染日益普及、医疗保健相关感染 (HAI) 意识不断提高以及对精确诊断测试的需求的影响。快速诊断测试（包括基于 PCR 的测试和免疫测量）的出现进一步刺激了市场。一个值得注意的机会在于人工智慧和机器学习的集成，以提高诊断的早期检测和预测准确性，从而推动创新。远端医疗的角色不断扩大也可能增强远距离诊断能力，并为市场扩张提供前沿。然而，与某些诊断测试相关的高成本以及需要熟练的专业人员解释复杂结果的限制。挑战包括核准新诊断的监管障碍以及开发高效且具有成本效益的诊断解决方案的竞赛。

创新领域包括次世代定序技术、多重检测以及可快速提供结果的就地检验设备的开发。此外，了解梭菌抗药性机制的研究和分析诊断资料的生物资讯解决方案也可能会推动重大进展。梭状芽孢桿菌诊断市场的性质是动态的，受到快速的技术进步和不断发展的优先考虑感染控制的医疗保健政策的影响。为了利用市场机会，相关人员应专注于合作研究，投资于简化和增强诊断工作流程的技术，并倡导政策支持以降低治疗成本。

市场动态：快速发展的梭菌诊断市场的关键市场洞察

供需的动态交互作用正在改变梭菌诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 梭菌相关疾病的高盛行率
    • 世界老年人口的增加
  • 市场限制因素
    • 诊断测试出现假阳性或假阴性的潜在风险
  • 市场机会
    • 诊断设备中的人工智慧整合和自动化
    • 采用可携式POCT 产品
  • 市场挑战
    • 发展中地区诊断中心的知名度和可用性有限

波特五力：开拓梭状芽孢桿菌诊断市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对梭菌诊断市场的影响

外部宏观环境因素在塑造梭菌诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解梭菌诊断市场的竞争状况

对梭菌诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵梭菌诊断市场供应商的绩效评估

FPNV 定位矩阵是评估梭菌诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定梭菌诊断市场成功之路的策略分析与建议

对于旨在加强其在全球市场的影响力的公司来说，对梭状芽孢桿菌诊断市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 梭菌相关疾病的高盛行率
      • 全球人口老化仍在持续
    • 抑制因素
      • 诊断测试出现假阳性或假阴性结果的潜在风险
    • 机会
      • 诊断设备中的人工智慧整合和自动化
      • 可携式POCT产品介绍
    • 任务
      • 发展中地区诊断中心的认知度和可用性有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 梭菌诊断药品市场诊断试验

  • 验血
  • 大肠镜检查/乙状结肠镜检查
  • 酵素免疫分析法
  • 核扩增试验（NAAT）
  • 反应（RT-PCR）
  • 即时聚合酵素链
  • 粪便检验

第 7 章 梭状芽孢桿菌诊断市场：依最终使用者分类

  • 诊断中心
  • 医院
  • 专科诊所

第八章北美和南美的梭菌诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区梭菌诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲梭状芽孢桿菌诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • altona Diagnostics GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Cepheid
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Ferring BV
  • Fujirebio Holdings Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Merck & Co., Inc.
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Olympus Corporation
  • Pfizer Inc.
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • Summit Therapeutics, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech Plc
  • ZeptoMetrix, LLC
Product Code: MRR-DD0700E81E26

The Clostridium Diagnostics Market was valued at USD 1.43 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 6.33%, to USD 2.20 billion by 2030.

The scope of Clostridium Diagnostics encompasses the detection, identification, and management of Clostridium infections, most notably Clostridium difficile, which is a significant concern in healthcare settings due to its correlation with antibiotic-related diarrhea and colitis. This diagnostic field is crucial as Clostridium infections can cause severe outcomes, necessitating timely and accurate diagnosis to mitigate the spread of infection and optimize treatment routes. Applications are prominent in hospitals, academic research centers, and diagnostic laboratories, where they support effective infection control and patient management strategies. The end-use scope extends from healthcare providers to biotechnology firms developing novel diagnostic technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.43 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 2.20 billion
CAGR (%) 6.33%

Market growth is influenced by the increasing prevalence of Clostridium infections, heightened awareness about healthcare-associated infections (HAI), and the demand for precise diagnostic testing. The advent of rapid diagnostic tests, including PCR-based and immunoassays, further fuels the market. A notable opportunity lies in the integration of artificial intelligence and machine learning to enhance early detection and prediction accuracy in diagnostics, driving innovation. The expanding role of telemedicine could also augment remote diagnostic capabilities, presenting a frontier for market expansion. However, limitations revolve around high costs associated with certain diagnostic tests and the need for skilled professionals to interpret complex results. Challenges include the regulatory hurdles for new diagnostic approvals and competition in developing efficient, cost-effective diagnostic solutions.

Innovation areas include the development of next-generation sequencing technologies, multiplex assays, and point-of-care testing devices that deliver results promptly. Additionally, research concentrated on understanding Clostridium resistance mechanisms and bioinformatics solutions to analyze diagnostic data can spur significant advancements. The nature of the Clostridium Diagnostics market is dynamic, shaped by rapid technological advancements and evolving healthcare policies prioritizing infection control. To capitalize on market opportunities, stakeholders should focus on collaborative research efforts and invest in technologies that streamline and enhance diagnostic workflows while advocating for policy-driven support to reduce treatment costs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clostridium Diagnostics Market

The Clostridium Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of clostridium-related disease
    • Growing geriatric population globally
  • Market Restraints
    • Potential risk of false positive or false negative results through diagnostic test
  • Market Opportunities
    • AI integration and automation in diagnostic devices
    • Adoption of portable POCT products
  • Market Challenges
    • Limited awarness and availability of diagnostic centers in developing areas

Porter's Five Forces: A Strategic Tool for Navigating the Clostridium Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clostridium Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clostridium Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clostridium Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clostridium Diagnostics Market

A detailed market share analysis in the Clostridium Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clostridium Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clostridium Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clostridium Diagnostics Market

A strategic analysis of the Clostridium Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clostridium Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, altona Diagnostics GmbH, Beckman Coulter, Inc., Becton, Dickinson & Company, bioMerieux SA, Cepheid, DiaSorin SpA, F. Hoffmann-La Roche AG, Ferring BV, Fujirebio Holdings Inc., Hologic, Inc., Luminex Corporation, Merck & Co., Inc., Meridian Bioscience, Inc., Molbio Diagnostics Pvt. Ltd., Olympus Corporation, Pfizer Inc., QIAGEN NV, Quidel Corporation, R-Biopharm AG, Summit Therapeutics, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech Plc, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Clostridium Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diagnostic Test, market is studied across Blood Test, Colonoscopy/Sigmoidoscopy, Enzyme Immunoassays, Nucleic Amplification Tests (NAAT), Reaction (RT-PCR), Real-Time Polymerase Chain, and Stool Test.
  • Based on End User, market is studied across Diagnostic Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of clostridium-related disease
      • 5.1.1.2. Growing geriatric population globally
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of false positive or false negative results through diagnostic test
    • 5.1.3. Opportunities
      • 5.1.3.1. AI integration and automation in diagnostic devices
      • 5.1.3.2. Adoption of portable POCT products
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awarness and availability of diagnostic centers in developing areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clostridium Diagnostics Market, by Diagnostic Test

  • 6.1. Introduction
  • 6.2. Blood Test
  • 6.3. Colonoscopy/Sigmoidoscopy
  • 6.4. Enzyme Immunoassays
  • 6.5. Nucleic Amplification Tests (NAAT)
  • 6.6. Reaction (RT-PCR)
  • 6.7. Real-Time Polymerase Chain
  • 6.8. Stool Test

7. Clostridium Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Clostridium Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clostridium Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Clostridium Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. altona Diagnostics GmbH
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson & Company
  • 5. bioMerieux SA
  • 6. Cepheid
  • 7. DiaSorin SpA
  • 8. F. Hoffmann-La Roche AG
  • 9. Ferring BV
  • 10. Fujirebio Holdings Inc.
  • 11. Hologic, Inc.
  • 12. Luminex Corporation
  • 13. Merck & Co., Inc.
  • 14. Meridian Bioscience, Inc.
  • 15. Molbio Diagnostics Pvt. Ltd.
  • 16. Olympus Corporation
  • 17. Pfizer Inc.
  • 18. QIAGEN NV
  • 19. Quidel Corporation
  • 20. R-Biopharm AG
  • 21. Summit Therapeutics, Inc.
  • 22. Sysmex Corporation
  • 23. Thermo Fisher Scientific, Inc.
  • 24. Trinity Biotech Plc
  • 25. ZeptoMetrix, LLC

LIST OF FIGURES

  • FIGURE 1. CLOSTRIDIUM DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLOSTRIDIUM DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLOSTRIDIUM DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COLONOSCOPY/SIGMOIDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY NUCLEIC AMPLIFICATION TESTS (NAAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TEST, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM CLOSTRIDIUM DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. CLOSTRIDIUM DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. CLOSTRIDIUM DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023